You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 9, 2024

Litigation Details for Kove IO, Inc. v. Amazon Web Services, Inc. (N.D. Ill. 2018)


✉ Email this page to a colleague

« Back to Dashboard


Kove IO, Inc. v. Amazon Web Services, Inc. (N.D. Ill. 2018)

Docket ⤷  Try a Trial Date Filed 2018-12-12
Court District Court, N.D. Illinois Date Terminated
Cause 35:271 Patent Infringement Assigned To Rebecca R. Pallmeyer
Jury Demand Both Referred To
Parties AMAZON WEB SERVICES, INC.; KOVE IO, INC.
Patents 10,022,474; 10,029,011; 10,029,015; 10,039,800; 6,028,222; 6,462,017; 6,465,006; 6,814,978; 7,014,098; 7,198,581; 7,674,014; 8,344,011; 8,445,003; 8,507,007; 8,568,233; 9,000,002; 9,000,011; 9,024,096; 9,074,005; 9,101,591; 9,101,592; 9,101,810; 9,415,008; 9,534,008; 9,587,003; 9,669,008
Attorneys Adam Unikowsky; Christine E Lehman; Courtland Reichman; Holly Hannah Campbell; Jaime Francisco Cardenas-Navia; Jennifer Estremera; Joachim Steinberg; Kate Falkenstien; Khue Hoang; Michael G Flanigan; Michael Glenn Babbitt; Michael Thomas Werner; Michael Walton Marvin; Phillip Lee; Rahul Sarkar; Renato T. Mariotti; Sarah Jorgensen; Shawna L Ballard; Terri Lynn Mascherin; Timothy Joseph Barron; Wesley White
Firms Jenner & Block LLP; Jenner & Block, LLP; Reichman Jorgensen LLP; Thompson Coburn LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Kove IO, Inc. v. Amazon Web Services, Inc.

Details for Kove IO, Inc. v. Amazon Web Services, Inc. (N.D. Ill. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-05-01 132 (“AWS”) of infringing U.S. Patent Nos. 7,233,978, 7,103,640, and 7,814,170. Pursuant to Federal Rule…’640 patent application—the ’978 patent is not a continuation of the ’640 patent. Claims 1, 3, 6, 10,…claim 18 of the ’640 patent and claim 6 of the ’170 patent. Claim 1 of the ’978 patent recites a “system …the ’978 patent is obvious in view of claim 18 of the ’640 patent and claim 6 of the ’170 patent. Claim…claim 18 of the ’640 patent and claim 6 of the ’170 patent. Claim 31 of the ’978 patent recites a “system External link to document
2020-10-13 221 Appendix Part 2 A20 5,781,725 07/14/98 SAITO A21 5,774,670 … A20 5,781,725 07/14/98 SAITO A21 5,774,670 … ..... A20 5,781,725 07/14/98 SAITO A21 5,… -. A20 5,781,725 07/14/98 SAITO ..l I…Division for issuance of a patent. The patent term adjustment indicated on the patent (as shown on the Issue External link to document
2021-09-09 401 Exhibit F ;2<>5B58131 ?@41@-.81.18;C-??19.8102>;9@415:-8'>-:?/>5<@I'> J?4;C?@41 …December 2018 10 April 2024 1:18-cv-08175 Patent Both District Court, N.D. Illinois External link to document
2023-10-05 690 Exhibit 48 Report at ¶ 109, FNs 134 and 139. 18 6/28/222 ’978 patent reexam Non-Final Office Action at 1, 35-…90/019,034 (“9/28/22 ’978 patent reexam response”). 11 8/4/22 ’640 patent reexam response at 23-24 …14 8/4/22 ’640 patent reexam response at 23-24. 15 Id. 16 8/11/22 ’170 patent reexam response …18; see also Karger ’420 patent at 3:23-50. 6:29-41, 10:22-34 and ’618 patent at 3:18-44, 6:21-33, 10:… ’640 Patent 374. Kove asserts claims 17, 18, and 24 of the ’640 patent. Claims 17 External link to document
2023-11-15 709 Exhibit K51 (PUBLIC) :15 765:6 separately 567:10,22 474:2,3 475:5 584:13,21 selected 781… 8 submitted to the patent office about the 9 patents-in-suit to prepare for your …21 in the '978 patent, which also is 10 figure in the other patents-in-suit, we see an …the claims in the earlier patent 12 and the claim in the later patent to identify any 13 …statements to the patent office that 15 Claims 1, 6 and 15 of the '170 patent require a 16 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.